EP0515128A1 - Matériau à l'halogénure d'argent pour photographie en couleurs - Google Patents

Matériau à l'halogénure d'argent pour photographie en couleurs Download PDF

Info

Publication number
EP0515128A1
EP0515128A1 EP92304489A EP92304489A EP0515128A1 EP 0515128 A1 EP0515128 A1 EP 0515128A1 EP 92304489 A EP92304489 A EP 92304489A EP 92304489 A EP92304489 A EP 92304489A EP 0515128 A1 EP0515128 A1 EP 0515128A1
Authority
EP
European Patent Office
Prior art keywords
group
silver halide
formula
represent
sensitive material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP92304489A
Other languages
German (de)
English (en)
Inventor
Shigeto C/O Konica Corporation Hirabayashi
Katsumasa c/o Konica Corporation Yamazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Konica Minolta Inc
Original Assignee
Konica Minolta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP14790891A external-priority patent/JPH04346344A/ja
Priority claimed from JP14790591A external-priority patent/JPH04346341A/ja
Priority claimed from JP29252891A external-priority patent/JPH05100389A/ja
Application filed by Konica Minolta Inc filed Critical Konica Minolta Inc
Publication of EP0515128A1 publication Critical patent/EP0515128A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
    • G03C7/00—Multicolour photographic processes or agents therefor; Regeneration of such processing agents; Photosensitive materials for multicolour processes
    • G03C7/30—Colour processes using colour-coupling substances; Materials therefor; Preparing or processing such materials
    • G03C7/3003—Materials characterised by the use of combinations of photographic compounds known as such, or by a particular location in the photographic element
    • G03C7/3005—Combinations of couplers and photographic additives
    • G03C7/3008—Combinations of couplers having the coupling site in rings of cyclic compounds and photographic additives
    • G03C7/301—Combinations of couplers having the coupling site in pyrazoloazole rings and photographic additives
EP92304489A 1991-05-23 1992-05-18 Matériau à l'halogénure d'argent pour photographie en couleurs Withdrawn EP0515128A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP147905/91 1991-05-23
JP147908/91 1991-05-23
JP14790891A JPH04346344A (ja) 1991-05-23 1991-05-23 ハロゲン化銀カラー写真感光材料
JP14790591A JPH04346341A (ja) 1991-05-23 1991-05-23 ハロゲン化銀カラー写真感光材料
JP29252891A JPH05100389A (ja) 1991-10-11 1991-10-11 ハロゲン化銀カラー写真感光材料
JP292528/91 1991-10-11

Publications (1)

Publication Number Publication Date
EP0515128A1 true EP0515128A1 (fr) 1992-11-25

Family

ID=27319440

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92304489A Withdrawn EP0515128A1 (fr) 1991-05-23 1992-05-18 Matériau à l'halogénure d'argent pour photographie en couleurs

Country Status (1)

Country Link
EP (1) EP0515128A1 (fr)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2313919A (en) * 1996-06-07 1997-12-10 Eastman Kodak Co Colour photographic paper with reduced interlayer effects
WO2006011719A1 (fr) * 2004-07-28 2006-02-02 B & C Biopharm Co., Ltd. Derives d'acide sulfamoylbenzoique n-substitue, leur procede de preparation et composition pharmaceutique antivirale les contenant
US7514583B2 (en) 2002-05-31 2009-04-07 Proteotech, Inc. Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
US8754133B2 (en) 2001-11-02 2014-06-17 Proteotech, Inc. Compounds, compositions and methods for the treatment of inflammatory diseases
US9173939B2 (en) 2013-05-10 2015-11-03 The University Of British Columbia Ester derivatives of androgen receptor modulators and methods for their use
US9365510B2 (en) 2012-04-16 2016-06-14 British Columbia Cancer Agency Branch Aziridine bisphenol ethers and related compounds and methods for their use
US9375496B2 (en) 2013-09-09 2016-06-28 British Columbia Cancer Agency Branch Halogenated compounds for cancer imaging and treatment and methods for their use
US9388112B2 (en) 2010-01-06 2016-07-12 The University Of British Columbia Bisphenol derivatives and their use as androgen receptor activity modulators
US9862667B2 (en) 2008-07-02 2018-01-09 The University Of British Columbia Diglycidic ether derivative therapeutics and methods for their use
US10471023B2 (en) 2015-03-12 2019-11-12 British Columbia Cancer Agency Branch Bisphenol ether derivatives and methods for using the same
US10654811B2 (en) 2015-01-13 2020-05-19 The University Of British Columbia Heterocyclic compounds for cancer imaging and treatment and methods for their use
US11059795B2 (en) 2018-10-18 2021-07-13 Essa Pharma, Inc. Androgen receptor modulators and methods for their use
US11142508B2 (en) 2016-04-15 2021-10-12 The University Of British Columbia Bisphenol derivatives and their use as androgen receptor activity modulators
US11242324B2 (en) 2020-04-17 2022-02-08 Essa Pharma, Inc. Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereof
US11485713B2 (en) 2018-05-25 2022-11-01 Essa Pharma, Inc. Androgen receptor modulators and methods for their use

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0192199A2 (fr) * 1985-02-16 1986-08-27 Konica Corporation Matériau photographique sensible à la lumière
EP0286431A1 (fr) * 1987-04-10 1988-10-12 Konica Corporation Matériau photographique couleur à l'halogénure d'argent sensible à la lumière
EP0422595A1 (fr) * 1989-10-12 1991-04-17 Konica Corporation Matériau photographique couleur à l'halogénure d'argent sensible à la lumière
EP0457543A1 (fr) * 1990-05-17 1991-11-21 Konica Corporation Matériau photographique à l'halogénure d'argent sensible à la lumiÀ¨re capable de produire une image colorée à solidité améliorée

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0192199A2 (fr) * 1985-02-16 1986-08-27 Konica Corporation Matériau photographique sensible à la lumière
EP0286431A1 (fr) * 1987-04-10 1988-10-12 Konica Corporation Matériau photographique couleur à l'halogénure d'argent sensible à la lumière
EP0422595A1 (fr) * 1989-10-12 1991-04-17 Konica Corporation Matériau photographique couleur à l'halogénure d'argent sensible à la lumière
EP0457543A1 (fr) * 1990-05-17 1991-11-21 Konica Corporation Matériau photographique à l'halogénure d'argent sensible à la lumiÀ¨re capable de produire une image colorée à solidité améliorée

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2313919A (en) * 1996-06-07 1997-12-10 Eastman Kodak Co Colour photographic paper with reduced interlayer effects
US5736303A (en) * 1996-06-07 1998-04-07 Eastman Kodak Company Color photographic paper with reduced interlayer effects
US8754133B2 (en) 2001-11-02 2014-06-17 Proteotech, Inc. Compounds, compositions and methods for the treatment of inflammatory diseases
US7514583B2 (en) 2002-05-31 2009-04-07 Proteotech, Inc. Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
US8163957B2 (en) 2002-05-31 2012-04-24 Proteotech, Inc. Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
WO2006011719A1 (fr) * 2004-07-28 2006-02-02 B & C Biopharm Co., Ltd. Derives d'acide sulfamoylbenzoique n-substitue, leur procede de preparation et composition pharmaceutique antivirale les contenant
US9862667B2 (en) 2008-07-02 2018-01-09 The University Of British Columbia Diglycidic ether derivative therapeutics and methods for their use
US9388112B2 (en) 2010-01-06 2016-07-12 The University Of British Columbia Bisphenol derivatives and their use as androgen receptor activity modulators
US9365510B2 (en) 2012-04-16 2016-06-14 British Columbia Cancer Agency Branch Aziridine bisphenol ethers and related compounds and methods for their use
US9173939B2 (en) 2013-05-10 2015-11-03 The University Of British Columbia Ester derivatives of androgen receptor modulators and methods for their use
US9375496B2 (en) 2013-09-09 2016-06-28 British Columbia Cancer Agency Branch Halogenated compounds for cancer imaging and treatment and methods for their use
US10654811B2 (en) 2015-01-13 2020-05-19 The University Of British Columbia Heterocyclic compounds for cancer imaging and treatment and methods for their use
US11345670B2 (en) 2015-01-13 2022-05-31 The University Of British Columbia Heterocyclic compounds for cancer imaging and treatment and methods for their use
US11779550B2 (en) 2015-03-12 2023-10-10 The University Of British Columbia Bisphenol ether derivatives and methods for using the same
US10471023B2 (en) 2015-03-12 2019-11-12 British Columbia Cancer Agency Branch Bisphenol ether derivatives and methods for using the same
US11142508B2 (en) 2016-04-15 2021-10-12 The University Of British Columbia Bisphenol derivatives and their use as androgen receptor activity modulators
US11919874B2 (en) 2016-04-15 2024-03-05 The University Of British Columbia Bisphenol derivatives and their use as androgen receptor activity modulators
US11485713B2 (en) 2018-05-25 2022-11-01 Essa Pharma, Inc. Androgen receptor modulators and methods for their use
US11059795B2 (en) 2018-10-18 2021-07-13 Essa Pharma, Inc. Androgen receptor modulators and methods for their use
US11242324B2 (en) 2020-04-17 2022-02-08 Essa Pharma, Inc. Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereof
US11518747B2 (en) 2020-04-17 2022-12-06 Essa Pharma, Inc. Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof
US11814357B2 (en) 2020-04-17 2023-11-14 Essa Pharma Inc. Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof
US11358938B2 (en) 2020-04-17 2022-06-14 Essa Pharma, Inc. Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof

Similar Documents

Publication Publication Date Title
US4814262A (en) Silver halide photographic light-sensitive material to provide dye-image with improved color-fastness to light
EP0218266A2 (fr) Matériau photographique couleur à l'halogénure d'argent sensible à la lumière
EP0283324B1 (fr) Matériau photographique couleur à l'halogénure d'argent sensible à la lumière
EP0515128A1 (fr) Matériau à l'halogénure d'argent pour photographie en couleurs
EP0457543A1 (fr) Matériau photographique à l'halogénure d'argent sensible à la lumiÀ¨re capable de produire une image colorée à solidité améliorée
EP0273712B1 (fr) Matériau photographique à l'halogénure d'argent sensible à la lumière
EP0286431B1 (fr) Matériau photographique couleur à l'halogénure d'argent sensible à la lumière
EP0268496B1 (fr) Matériau photographique à l'halogénure d'argent sensible à la lumière adapté pour traitement rapide
EP0536889A1 (fr) Matériau photographique couleur à l'halogénure d'argent sensible à la lumière
US4994351A (en) Silver halide color photographic material
US5342746A (en) Method for the formation of color photographic materials with high coupling reactivity and reduced color developer PH sensitivity
US4945034A (en) Silver halide photographic light-sensitive material
US5576166A (en) Silver halide light-sensitive color photographic
EP0610029A1 (fr) Matériau photographique couleur à l'halogénure d'argent sensible à la lumière
EP0321190B1 (fr) Matériau photographique couleur à l'halogénure d'argent sensible à la lumière
EP0327274B1 (fr) Matériau photographique à l'halogénure d'argent sensible à la lumière
EP0350286A2 (fr) Matériau photographique à l'halogénure d'argent sensible à la lumière
EP0629912B1 (fr) Matériau photographique couleur à l'halogénure d'argent sensible à la lumière
US6010809A (en) Silver halide light-sensitive color photographic material
USH1127H (en) Silver halide photographic material
JP2838539B2 (ja) ハロゲン化銀写真感光材料
EP0306246A2 (fr) Matériau photographique à l'halogénure d'argent
US5683860A (en) Silver halide light-sensitive element
JPH0588324A (ja) ハロゲン化銀カラー写真感光材料
JP2613395B2 (ja) 直接ポジ型ハロゲン化銀写真感光材料

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB NL

17P Request for examination filed

Effective date: 19930506

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19931218